A detailed history of Insight 2811, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Insight 2811, Inc. holds 7,510 shares of MRK stock, worth $959,177. This represents 0.5% of its overall portfolio holdings.

Number of Shares
7,510
Previous 7,495 0.2%
Holding current value
$959,177
Previous $817,000 21.18%
% of portfolio
0.5%
Previous 0.44%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $1,698 - $1,979
15 Added 0.2%
7,510 $990,000
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $45,281 - $49,277
-452 Reduced 5.69%
7,495 $817,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $120,966 - $134,337
-1,175 Reduced 12.88%
7,947 $818,000
Q2 2023

Aug 04, 2023

SELL
$108.61 - $118.38 $13,467 - $14,679
-124 Reduced 1.34%
9,122 $1.05 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $12,970 - $14,472
-126 Reduced 1.34%
9,246 $983,000
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $94,959 - $121,751
1,086 Added 13.11%
9,372 $1.04 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $7,438 - $8,356
88 Added 1.07%
8,286 $714,000
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $8,349 - $9,464
-100 Reduced 1.21%
8,198 $747,000
Q1 2022

May 06, 2022

BUY
$73.51 - $82.4 $22,420 - $25,132
305 Added 3.82%
8,298 $681,000
Q4 2021

Feb 01, 2022

BUY
$72.28 - $90.54 $7,878 - $9,868
109 Added 1.38%
7,993 $613,000
Q3 2021

Nov 04, 2021

SELL
$71.68 - $78.83 $50,176 - $55,181
-700 Reduced 8.15%
7,884 $592,000
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $15,819 - $17,498
225 Added 2.69%
8,584 $668,000
Q1 2021

Apr 29, 2021

BUY
$68.86 - $81.11 $15,080 - $17,763
219 Added 2.69%
8,359 $644,000
Q4 2020

Jan 29, 2021

SELL
$71.77 - $79.65 $4,306 - $4,779
-60 Reduced 0.73%
8,140 $666,000
Q3 2020

Oct 20, 2020

SELL
$73.18 - $82.95 $21,954 - $24,885
-300 Reduced 3.53%
8,200 $680,000
Q2 2020

Jul 21, 2020

SELL
$70.42 - $80.13 $56,336 - $64,104
-800 Reduced 8.6%
8,500 $665,000
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $329,472 - $456,663
5,200 Added 126.83%
9,300 $716,000
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $31,032 - $35,016
-400 Reduced 8.89%
4,100 $373,000
Q3 2019

Oct 31, 2019

SELL
$76.08 - $82.93 $121,728 - $132,688
-1,600 Reduced 26.23%
4,500 $379,000
Q2 2019

Jul 09, 2019

BUY
$69.84 - $81.59 $230,472 - $269,247
3,300 Added 117.86%
6,100 $530,000
Q4 2018

Feb 25, 2019

BUY
$65.24 - $75.71 $182,672 - $211,987
2,800 New
2,800 $214,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Insight 2811, Inc. Portfolio

Follow Insight 2811, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight 2811, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Insight 2811, Inc. with notifications on news.